Chart, Financials, Historical Prices, Industry, Insider, Messages, News, Options, Profile, Reports, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-May-2013
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 14)
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
24-May-13New Constructs, LLCN/AGERN: Due Diligence Review: Forensic Earnings and Valuation13$25  View Abstract
24-May-13ValuEngine, Inc.N/AValuEngine Industry Report for Medical-biomed/genetics18$207  View Abstract
23-May-13ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for GERN11$126.50  View Abstract
20-May-13Pechala's ReportsLubomir PechalaGERON CORPORATION DELAWARE (GERN) - REPORT FOR ACTIVE TRADERS1$25  View Abstract
18-May-13Pechala's ReportsFrantisek PechalaGERON CORPORATION DELAWARE (GERN) 12-months forecast1$15  View Abstract
17-May-13Ford Investor Services, Inc.N/AIndustry Value Graph: ARRY , BCRX , DNDN , GERN , XOMA -- DRUGS3$34.50  View Abstract
17-May-13Ford Investor Services, Inc.N/AValue Graph: GERON -- GERN1$11.50  View Abstract
12-May-13TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: GERON CORP5$10  View Abstract
11-May-13S&P Capital IQ Quantitative ReportN/AGeron Corp6$69  View Abstract
5-May-13TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: GERON CORP5$10  View Abstract
Next 4
Independent Reports (Showing 1 to 10 of 14)
Release
Date [down]		 Contributor Author Title Pages Price More Info
24-May-13New Constructs, LLCN/AGERN: Due Diligence Review: Forensic Earnings and Valuation13$25View Abstract
24-May-13ValuEngine, Inc.N/AValuEngine Industry Report for Medical-biomed/genetics18$207View Abstract
23-May-13ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for GERN11$126.50View Abstract
20-May-13Pechala's ReportsLubomir PechalaGERON CORPORATION DELAWARE (GERN) - REPORT FOR ACTIVE TRADERS1$25View Abstract
18-May-13Pechala's ReportsFrantisek PechalaGERON CORPORATION DELAWARE (GERN) 12-months forecast1$15View Abstract
17-May-13Ford Investor Services, Inc.N/AIndustry Value Graph: ARRY , BCRX , DNDN , GERN , XOMA -- DRUGS3$34.50View Abstract
17-May-13Ford Investor Services, Inc.N/AValue Graph: GERON -- GERN1$11.50View Abstract
12-May-13TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: GERON CORP5$10View Abstract
11-May-13S&P Capital IQ Quantitative ReportN/AGeron Corp6$69View Abstract
5-May-13TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: GERON CORP5$10View Abstract
Next 4

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.